Anticardiolipin antibodies in haemodialysis patients and in renal transplant recipients: Prevalence and significance;Anticorpi anticardiolipina in pazienti in emodialisi e con trapianto renale: Prevalenza e significato

Recenti Progressi in Medicina

Volumn 89, Issue 9, 1998, Pages 434-437

  Ferlazzo, Benito ^a,b   Barrile, Angela ^a   Bonanno, Domenica ^a   Quattrocchi, Paolina ^a   Santoro, Domenico ^a   Savica, Vincenzo ^a   Bellinghieri, Guido ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b NONE   (Italy)

Author keywords

Anticardiolipin antibodies; Antiphospholipid antibodies; End stage renal disease; Haemodialysis

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; AGED; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; FEMALE; HUMAN; IMMUNOLOGY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

ADULT; AGED; ANTIBODIES, ANTICARDIOLIPIN; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 0032161915     PISSN: 00341193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Hughes GRV, Hanis EN, Gharavi AE. The anticardiolipin syndrome. J Rheumatol 1986; 13: 486-9.
2. Hughes GRV. The antiphospholipid syndrome. Ten years on. Lancet 1993; 342: 341-4.
3. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Int Med 1990; 112: 682-98.
4. Quereda C, Pardo A, Lamas S, Orofino L et al. Lupus-like in vitro anti-coagulant activity in end-stage renal disease. Nephron 1988; 49: 39-44.
5. Gronhagen-Riska C, Teppo AM, Helantera A, Honkanen E, Julkunen H. Raised concentrations of antibodies to cardiolipin in patients receiving dialysis. Br Med J 1990; 300: 1696-7.
6. Garcia-Martin F, De Arriba G, Carrascosa T et al. Anticardiolipin antibodies and lupus anticoagulant in end stage renal disease. Nephrol Dial Transplant 1991; 6: 543-7.
7. Kirschbaum B, Mullinax F, Curry N, Mallory J. Association between anticardiolipin antibodies and frequent clotting problems in haemodialysis patients. J Am Soc Nephrol 1991; 2: 332 (abstract).
8. Page B, Yazbeck F, Zingraff J, Bourquelot P. Clotting of vascular access in dialysis patients associated to anticardiolipin antibodies. Nephrol Dial Transplant 1992; 7: 733 (abstract).
9. Bala Subramanian V, Smith D, McMillan MA, Macdougall AI. Anticardiolipin antibodies in long-term dialysis patients. Nephrol Dial Transplant 1992; 7: 459 (abstract).
10. Chew SL, Lins RL, Daelemans R et al. Are antiphospholipid antibodies clinically relevant in dialysis patients? Nephrol Dial Transplant 1992; 14: 1194-8.
11. Sitter T, Schiffl H. Anticardiolipin antibodies in patients on regular haemodialysis. An epiphenomenon? Nephron 1993; 64: 655-6.
12. Phillips AO, Jones HW, Hambley H, Hillis AN, Hendry BM. Prevalence of lupus anticoagulant and anticardiolipin antibodies in haemodialysis patients. Nephron 1993; 65: 350-353.
13. Oymak O, Erdem Y, Yalcin AU et al. Increased prevalence of anticardiolipin antibodies in renal transplant recipients. Nephron 1955; 71: 469-70.
14. Prakash R, Mille III CC, Suki WN. Anticardiolipin antibody in patients on maintenance haemodialysis and its association with recurrent arteriovenous graft thrombosis Am J Kidney Dis 1995; 26: 347-52.
15. Bernis C, Munoz de Bustillo E, Requena MI et al. Are anticardiolipin antibodies clinically relevant in haemodialysis ? Proc European Dialysis and Transplant Association 1995; 177 (abstract).
16. Kang DH, Ryu SK, Choi KB, Yoon KI. Anticardiolipin antibodies (ACA) and lupus anticoagulant (LA): association with vascular access occlusion in haemodialysis (HD) patients. Proceedings European Dialysys and Transplant Association 1996; 265 (abstract).
17. Galli M, Comfurius P, Maassen C et al. Anticardiolipin antibodies are directed no to cardiolipin but to a protein cofactor. Lancet 1990; 335: 1544-47.
18. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta2-glycoprotein I. Proc Natl Acad Sci USA 1990; 87: 4120-4.